Hong Kong Enhances Expedited Drug Licensing Process; Adopts Refuse-To-File Tool

Two announcements by the Pharmacy and Poisons Board have implications for drug companies looking to register their products in Hong Kong.

Hong Kong is working on making its drug registration procedures more efficient • Source: Shutterstock

Hong Kong has introduced more measures to incentivize companies to submit their drug marketing applications using the “1+” mechanism it launched last November to speed up the registration of products containing new chemical or biological entities for life-threatening or severely-debilitating diseases.

In addition, the country has implemented a new refuse-to-file (RTF) mechanism to “enhance its timeliness and efficiency” in managing the review of applications for the initial

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Product Reviews

More from Pink Sheet